Differential expression of Bcl-2 and Bcl-xL in human small cell lung cancer (SCLC) and adenocarcinoma of the lung (ACL)

被引：0
|
作者：
Li, E
Xiao, H
Vikram, B
机构：
[1] NYU Med Ctr, New York, NY 10016 USA
[2] Montefiore Med Ctr, Bronx, NY 10467 USA
来源：
LABORATORY INVESTIGATION | 2001年 / 81卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1314
引用
收藏
页码：223A / 223A
页数：1
相关论文
共 50 条
  • [1] Differential expression of Bcl-2 and Bcl-xL in human small cell lung cancer (SCLC) and adenocarcinoma of the lung (ACL)
    Li, E
    Xiao, H
    Vikram, B
    MODERN PATHOLOGY, 2001, 14 (01) : 223A - 223A
  • [2] Combined inhibition of Bcl-2 and MCL-1 in small cell lung cancer (SCLC) is most effective in tumors with low Bcl-xL expression
    Drapkin, Benjamin J.
    Sanghavi, Sneha
    Myers, David T.
    Zhong, Jun
    Phat, Sarah
    Wang, Youzhen
    Halilovic, Ensar
    Golji, Javad
    Farago, Anna
    Morris, Erick
    Dyson, Nicholas J.
    CANCER RESEARCH, 2019, 79 (13)
  • [3] Targeting Bcl-2/Bcl-xl for small cell lung cancer treatment with LP-118
    Lee, Ling-Ling
    Chen, Huan
    Zhu, Cong
    Chen, Yao
    Feldmeier, Brianna
    Shen, Yue
    Chen, Yu
    Anthony, Stephen P.
    Tan, Fenlai
    Chen, Yi
    Dai, Bing
    CANCER RESEARCH, 2024, 84 (06)
  • [4] Bcl-xL, overexpressed in human lung adenocarcinoma (ACL), is an ideal target for antisense therapy
    Li, E
    Xiao, H
    Vikram, B
    LABORATORY INVESTIGATION, 2001, 81 (01) : 223A - 223A
  • [5] Bcl-xL, overexpressed in human lung adenocarcinoma (ACL), is an ideal target for antisense therapy
    Li, E
    Xiao, H
    Vikram, B
    MODERN PATHOLOGY, 2001, 14 (01) : 223A - 223A
  • [6] Radiosensitization by a novel Bcl-2 and Bcl-XL inhibitor S44563 in small-cell lung cancer
    Y Loriot
    P Mordant
    D Dugue
    O Geneste
    A Gombos
    P Opolon
    J Guegan
    J-L Perfettini
    A Pierre
    L K Berthier
    G Kroemer
    J C Soria
    S Depil
    E Deutsch
    Cell Death & Disease, 2014, 5 : e1423 - e1423
  • [7] Radiosensitization by a novel Bcl-2 and Bcl-XL inhibitor S44563 in small-cell lung cancer
    Loriot, Y.
    Mordant, P.
    Dugue, D.
    Geneste, O.
    Gombos, A.
    Opolon, P.
    Guegan, J.
    Perfettini, J-L
    Pierre, A.
    Berthier, L. K.
    Kroemer, G.
    Soria, J. C.
    Depil, S.
    Deutsch, E.
    CELL DEATH & DISEASE, 2014, 5 : e1423 - e1423
  • [8] EXPRESSION OF BCL-2 AND BCL-XL IN BREAST-CANCER
    CARROLL, AG
    LIPPMAN, ME
    MOLECULAR BIOLOGY OF THE CELL, 1995, 6 : 1439 - 1439
  • [9] Differential expression of Bcl-2, Bcl-XL and p53 in colorectal cancer
    Han, Hye Seung
    Park, Young-Mee
    Hwang, Tae Sook
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 (07) : 1108 - 1114
  • [10] BCL-2, BCL-XL, AND PP32/PHAPI IN RESECTED NON-SMALL CELL LUNG CANCER PATIENTS
    Schmidt, Lars Henning
    Kuemmel, Andreas
    Martin, Schuler M.
    Biesterfeld, Stefan
    Faldum, Andreas
    Sebastian, Martin
    Taube, Christian
    Buhl, Roland
    Wiewrodt, Rainer
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3479 - 3479
12345